Doximity (DOCS) Competitors

Doximity logo
$28.73 -0.88 (-2.96%)
Closing price 03:58 PM Eastern
Extended Trading
$28.74 +0.01 (+0.04%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DOCS vs. WAY, HTFL, SDGR, CERT, and TDOC

Should you buy Doximity stock or one of its competitors? Doximity's main competitors and comparable companies include Waystar (WAY), Heartflow (HTFL), Schrodinger (SDGR), Certara (CERT), and Teladoc Health (TDOC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Doximity compare to Waystar?

Doximity (NYSE:DOCS) and Waystar (NASDAQ:WAY) are both mid-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, analyst recommendations, profitability and dividends.

Doximity has a beta of 1.29, indicating that its share price is 29% more volatile than the broader market. Comparatively, Waystar has a beta of 0.11, indicating that its share price is 89% less volatile than the broader market.

Doximity has higher earnings, but lower revenue than Waystar. Waystar is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Doximity$644.86M8.20$196.05M$0.7241.16
Waystar$1.10B4.74$112.09M$0.6939.26

87.2% of Doximity shares are held by institutional investors. 31.8% of Doximity shares are held by insiders. Comparatively, 3.5% of Waystar shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Doximity had 8 more articles in the media than Waystar. MarketBeat recorded 11 mentions for Doximity and 3 mentions for Waystar. Doximity's average media sentiment score of 0.14 beat Waystar's score of 0.00 indicating that Doximity is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Doximity
2 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Waystar
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Doximity has a net margin of 21.12% compared to Waystar's net margin of 10.70%. Doximity's return on equity of 15.80% beat Waystar's return on equity.

Company Net Margins Return on Equity Return on Assets
Doximity21.12% 15.80% 13.38%
Waystar 10.70%6.91%4.67%

Doximity presently has a consensus target price of $30.59, suggesting a potential upside of 3.22%. Waystar has a consensus target price of $35.23, suggesting a potential upside of 30.04%. Given Waystar's stronger consensus rating and higher probable upside, analysts clearly believe Waystar is more favorable than Doximity.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Doximity
3 Sell rating(s)
14 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.20
Waystar
0 Sell rating(s)
4 Hold rating(s)
17 Buy rating(s)
2 Strong Buy rating(s)
2.91

Summary

Doximity beats Waystar on 12 of the 17 factors compared between the two stocks.

How does Doximity compare to Heartflow?

Doximity (NYSE:DOCS) and Heartflow (NASDAQ:HTFL) are both mid-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, institutional ownership, dividends, analyst recommendations, risk and earnings.

Doximity has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Doximity$644.86M8.20$196.05M$0.7241.16
Heartflow$176.03M22.28-$116.79M-$0.92N/A

In the previous week, Heartflow had 18 more articles in the media than Doximity. MarketBeat recorded 29 mentions for Heartflow and 11 mentions for Doximity. Heartflow's average media sentiment score of 0.46 beat Doximity's score of 0.14 indicating that Heartflow is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Doximity
2 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Heartflow
8 Very Positive mention(s)
2 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Doximity has a net margin of 21.12% compared to Heartflow's net margin of -33.11%. Doximity's return on equity of 15.80% beat Heartflow's return on equity.

Company Net Margins Return on Equity Return on Assets
Doximity21.12% 15.80% 13.38%
Heartflow -33.11%-20.53%-16.81%

Doximity has a beta of 1.29, suggesting that its share price is 29% more volatile than the broader market. Comparatively, Heartflow has a beta of 2.5, suggesting that its share price is 150% more volatile than the broader market.

Doximity presently has a consensus target price of $30.59, suggesting a potential upside of 3.22%. Heartflow has a consensus target price of $60.13, suggesting a potential upside of 34.72%. Given Heartflow's stronger consensus rating and higher possible upside, analysts plainly believe Heartflow is more favorable than Doximity.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Doximity
3 Sell rating(s)
14 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.20
Heartflow
1 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.75

87.2% of Doximity shares are held by institutional investors. 31.8% of Doximity shares are held by insiders. Comparatively, 7.7% of Heartflow shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Doximity beats Heartflow on 8 of the 15 factors compared between the two stocks.

How does Doximity compare to Schrodinger?

Doximity (NYSE:DOCS) and Schrodinger (NASDAQ:SDGR) are both mid-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, valuation, dividends, institutional ownership, earnings and media sentiment.

Doximity presently has a consensus price target of $30.59, indicating a potential upside of 3.22%. Schrodinger has a consensus price target of $26.67, indicating a potential upside of 1.24%. Given Doximity's higher possible upside, equities research analysts plainly believe Doximity is more favorable than Schrodinger.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Doximity
3 Sell rating(s)
14 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.20
Schrodinger
1 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.38

In the previous week, Doximity had 5 more articles in the media than Schrodinger. MarketBeat recorded 11 mentions for Doximity and 6 mentions for Schrodinger. Schrodinger's average media sentiment score of 0.63 beat Doximity's score of 0.14 indicating that Schrodinger is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Doximity
2 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Schrodinger
3 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Doximity has a net margin of 21.12% compared to Schrodinger's net margin of -22.02%. Doximity's return on equity of 15.80% beat Schrodinger's return on equity.

Company Net Margins Return on Equity Return on Assets
Doximity21.12% 15.80% 13.38%
Schrodinger -22.02%-18.12%-9.07%

87.2% of Doximity shares are owned by institutional investors. Comparatively, 79.1% of Schrodinger shares are owned by institutional investors. 31.8% of Doximity shares are owned by company insiders. Comparatively, 10.1% of Schrodinger shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Doximity has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Doximity$644.86M8.20$196.05M$0.7241.16
Schrodinger$255.87M7.73-$103.26M-$0.79N/A

Doximity has a beta of 1.29, suggesting that its share price is 29% more volatile than the broader market. Comparatively, Schrodinger has a beta of 1.69, suggesting that its share price is 69% more volatile than the broader market.

Summary

Doximity beats Schrodinger on 13 of the 16 factors compared between the two stocks.

How does Doximity compare to Certara?

Certara (NASDAQ:CERT) and Doximity (NYSE:DOCS) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, media sentiment, institutional ownership, analyst recommendations, profitability, valuation, earnings and risk.

Doximity has a net margin of 21.12% compared to Certara's net margin of -16.14%. Doximity's return on equity of 15.80% beat Certara's return on equity.

Company Net Margins Return on Equity Return on Assets
Certara-16.14% 3.36% 2.31%
Doximity 21.12%15.80%13.38%

Certara currently has a consensus target price of $9.92, suggesting a potential downside of 7.15%. Doximity has a consensus target price of $30.59, suggesting a potential upside of 3.22%. Given Doximity's higher possible upside, analysts plainly believe Doximity is more favorable than Certara.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Certara
1 Sell rating(s)
7 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.38
Doximity
3 Sell rating(s)
14 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.20

74.0% of Certara shares are held by institutional investors. Comparatively, 87.2% of Doximity shares are held by institutional investors. 1.1% of Certara shares are held by company insiders. Comparatively, 31.8% of Doximity shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Doximity has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Certara$418.84M3.89-$1.60M-$0.42N/A
Doximity$644.86M8.20$196.05M$0.7241.16

In the previous week, Doximity had 9 more articles in the media than Certara. MarketBeat recorded 11 mentions for Doximity and 2 mentions for Certara. Certara's average media sentiment score of 0.54 beat Doximity's score of 0.14 indicating that Certara is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Certara
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Doximity
2 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Certara has a beta of 1.3, meaning that its stock price is 30% more volatile than the broader market. Comparatively, Doximity has a beta of 1.29, meaning that its stock price is 29% more volatile than the broader market.

Summary

Doximity beats Certara on 13 of the 17 factors compared between the two stocks.

How does Doximity compare to Teladoc Health?

Teladoc Health (NYSE:TDOC) and Doximity (NYSE:DOCS) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, risk, dividends, valuation, institutional ownership, profitability, earnings and analyst recommendations.

In the previous week, Doximity had 3 more articles in the media than Teladoc Health. MarketBeat recorded 11 mentions for Doximity and 8 mentions for Teladoc Health. Teladoc Health's average media sentiment score of 1.13 beat Doximity's score of 0.14 indicating that Teladoc Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Teladoc Health
5 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Doximity
2 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Teladoc Health has a beta of 2, suggesting that its stock price is 100% more volatile than the broader market. Comparatively, Doximity has a beta of 1.29, suggesting that its stock price is 29% more volatile than the broader market.

Doximity has a net margin of 21.12% compared to Teladoc Health's net margin of -6.27%. Doximity's return on equity of 15.80% beat Teladoc Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Teladoc Health-6.27% -11.63% -5.53%
Doximity 21.12%15.80%13.38%

76.8% of Teladoc Health shares are owned by institutional investors. Comparatively, 87.2% of Doximity shares are owned by institutional investors. 0.7% of Teladoc Health shares are owned by company insiders. Comparatively, 31.8% of Doximity shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Teladoc Health presently has a consensus price target of $8.60, indicating a potential upside of 10.19%. Doximity has a consensus price target of $30.59, indicating a potential upside of 3.22%. Given Teladoc Health's higher probable upside, equities analysts plainly believe Teladoc Health is more favorable than Doximity.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Teladoc Health
2 Sell rating(s)
11 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.17
Doximity
3 Sell rating(s)
14 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.20

Doximity has lower revenue, but higher earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Teladoc Health$2.53B0.56-$200.32M-$0.86N/A
Doximity$644.86M8.20$196.05M$0.7241.16

Summary

Doximity beats Teladoc Health on 12 of the 16 factors compared between the two stocks.

Get Doximity News Delivered to You Automatically

Sign up to receive the latest news and ratings for DOCS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DOCS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DOCS vs. The Competition

MetricDoximityHealthcare Technology IndustryHealthcare SectorNYSE Exchange
Market Cap$5.13B$1.77B$7.42B$20.48B
Dividend YieldN/A3.90%2.48%3.87%
P/E Ratio39.9138.5532.4527.92
Price / Sales7.955.188.083.58
Price / Cash24.7415.4220.7215.35
Price / Book5.534.494.313.40
Net Income$196.05M-$19.09M$3.51B$1.07B
7 Day Performance-13.82%-8.68%-7.89%-7.10%
1 Month Performance-13.84%-13.01%-10.43%-7.15%
1 Year PerformanceN/A-14.83%-2.77%2.58%

Doximity Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DOCS
Doximity
3.1371 of 5 stars
$28.73
-3.0%
$30.59
+6.5%
N/A$5.13B$644.86M39.91880
WAY
Waystar
2.8694 of 5 stars
$28.44
+1.6%
$35.23
+23.9%
-22.2%$5.49B$1.26B41.371,700
HTFL
Heartflow
3.8301 of 5 stars
$48.16
-0.6%
$60.13
+24.8%
+63.9%$4.19B$212.07MN/A843
SDGR
Schrodinger
3.0401 of 5 stars
$27.70
-6.2%
$26.67
-3.7%
+56.3%$2.05B$269.20MN/A850
CERT
Certara
1.5579 of 5 stars
$11.27
-2.6%
$9.92
-12.0%
+28.8%$1.72B$425.76MN/A1,576

Related Companies and Tools


This page (NYSE:DOCS) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners